Fe (III) 模板的Gd (III) 自组装 - - 迈向宏分子MRI对比剂的新途径
Valérie C Pierre1, Mauro Botta, Silvio Aime
1Department of Chemistry, University of California, Berkeley, California 94720-1460, USA.
Journal of the American Chemical Society
|July 20, 2006
概括
研究人员使用加多 (Gd(III)) 复合体开发了新的超分子. 这些集群显示出作为先进的MRI对比剂的前景,因为它们在高磁场下具有高效的放松性.
科学领域:
- 超分子化学 超分子化学
- 无机化学 无机化学 有机化学
- 材料科学 材料科学 材料科学
背景情况:
- 加多 (Gd(III)) 复合物因其磁性特性而受到广泛的研究.
- 开发高效的MRI对比剂需要优化放松性和稳定性.
- 超分子自我组装为设计复杂的分子架构提供了一条途径.
研究的目的:
- 为了合成和描述Gd(III) 酸胺复合物的新型超分子.
- 评估这些超分子作为MRI对比剂的潜力.
- 为了研究超分子结构和放松性之间的关系.
主要方法:
- 在Fe (III) 甲基甲胺模板周围自组装Gd (III) 酸胺复合体.
- 超分子集群结构和属性的表征.
- 在高磁场下放松性测量.
主要成果:
- 成功合成了由Fe (III) 中心模拟的超分子.
- Gd(III) 离子与快速交换的水分子协调.
- 超分子的高刚性导致了旋转相关联时间的增加.
- 在高磁场下表现出高放松度.
结论:
- 自组装的Gd(III) 超分子团表现出适用于MRI对比剂的特性.
- 设计策略通过受控的超分子架构有效地增强了放松性.
- 这些发现为开发下一代MRI对比剂开辟了道路.
相关概念视频
03:02Colors and Magnetism
Color in Coordination Complexes
When atoms or molecules absorb light at the proper frequency, their electrons are excited to higher-energy orbitals. For many main group atoms and molecules, the absorbed photons are in the ultraviolet range of the electromagnetic spectrum, which cannot be detected by the human eye. For coordination compounds, the energy difference between the d orbitals often allows photons in the visible range to be absorbed and emitted, which is seen as colors by the human eye.
When atoms or molecules absorb light at the proper frequency, their electrons are excited to higher-energy orbitals. For many main group atoms and molecules, the absorbed photons are in the ultraviolet range of the electromagnetic spectrum, which cannot be detected by the human eye. For coordination compounds, the energy difference between the d orbitals often allows photons in the visible range to be absorbed and emitted, which is seen as colors by the human eye.
01:24Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...